AKT1 and neoplasm: As previous studies have documented that treatment with PS reduces the levels of p-AKT (Ser473) and inhibits TORC1 activity in other tumor cell types [38], we next determined whether PS treatment also depleted TORC1 and TORC2 activity in PDAC cells.